Genmab shares jumped after the biotechnology company and partner AbbVie said their Epkinly drug helped extend the time patients with a common type of lymphoma lived without the disease getting worse ...

S&P 500 futures are up 0.2%. Dow Jones Industrial Average futures are up 0.4%. Nasdaq 100 futures are up 0.2%. U.S. stocks are set to climb on Tuesday after the Nasdaq rose to a record high on Monday.

Pal Group Holdings Co. Ltd. (2726.TO) Japan Half-Year Ended August 31 GROUP 2026 2025 Revenue Y121.93 bln Y117.08 bln Operating Profit Y14.25 bln Y14.10 bln Pretax Profit Y14.22 bln Y14.07 bln Net ...

Felissimo Corp. (3396.TO) Japan Half-Year Ended August 31 GROUP 2026 2025 Revenue Y14.15 bln Y14.26 bln Operating Profit Y122.00 mln Y202.00 mln Pretax Profit Y262.00 mln Y247.00 mln Net Profit ...

Nakakita Seisakusho Co. Ltd. (6496.TO) Japan 1st Quarter Ended August 31 GROUP 2026 2025 Revenue Y7.20 bln Y7.08 bln Operating Profit Y253.00 mln Y386.00 mln Pretax Profit Y443.00 mln Y586.00 mln Net ...

Norwegian Air Shuttle's passenger numbers rose in September compared with the same month a year earlier. The airline said Tuesday that it carried 2.45 million passengers in the month, up 6.3% on year ...

Bond yields and equity prices typically move inversely to one another, partly because rising yields can drag on corporate profits by hiking borrowing costs. However, the bond sell-off hasn't dampened ...

SYDNEY--Australia's Macquarie Group has taken a stake in Singapore-based data-center developer Zerra DC, increasing its exposure to artificial intelligence-driven infrastructure growth in the ...

The Energy Department has given nuclear-energy company Vistra a conditional loan commitment of up to $4.2 billion. The commitment is meant to finance nuclear uprates and modernization across Vistra's ...

Neighborhood Intelligence, the company previously known as Bed, Bath and Beyond, said its finance chief will leave the company after calling off its merger with Fathom. With Brian LaRose departing, ...

Standard BioTools agreed to sell its Microfluidics business to the investment firm Archimed. Shares gained 3% to $0.79 after the bell on Monday.

Standard BioTools said it agreed to sell its Microfluidics business to Archimed, an investment firm focused exclusively on healthcare industries. Standard BioTools said Monday its Microfluidics ...